REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trialJavier Martín‐Broto, Virginia Martínez-Marín, Javier Martínez‐Trufero et al.|Molecular Cancer|2023Cited by 27
Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS)Marta Ramírez-Calvo, José Antonio López‐Guerrero, Zaida García‐Casado et al.|Hereditary Cancer in Clinical Practice|2019Cited by 15